CN102670817A - Medicament for treating various blood diseases such as thrombocytopenia, purpura and leukaemia - Google Patents

Medicament for treating various blood diseases such as thrombocytopenia, purpura and leukaemia Download PDF

Info

Publication number
CN102670817A
CN102670817A CN201210115326XA CN201210115326A CN102670817A CN 102670817 A CN102670817 A CN 102670817A CN 201210115326X A CN201210115326X A CN 201210115326XA CN 201210115326 A CN201210115326 A CN 201210115326A CN 102670817 A CN102670817 A CN 102670817A
Authority
CN
China
Prior art keywords
parts
radix
purpura
thrombocytopenia
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201210115326XA
Other languages
Chinese (zh)
Inventor
陈玉堂
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201210115326XA priority Critical patent/CN102670817A/en
Publication of CN102670817A publication Critical patent/CN102670817A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to a medicament [Xiaolingtang No.25] for treating various blood diseases such as thrombocytopenia, purpura and leukaemia. The medicament comprises ganoderma lucidum, ginseng, herba epimedii, astragalus root, rhubarb, cordyceps, houttuynia cordata and licorice. The medicament for treating various blood diseases such as thrombocytopenia, purpura and leukaemia is made of pure traditional Chinese medicinal materials, and has the advantages of an effect of restoring a hematopoietic function, good treatment effect, small side effect, short period of treatment and the like; and the formula of the medicament can be used for treating various blood diseases at the same time. The medicament has the characteristics of quick response and no relapse after healing when used for treating various blood diseases such as thrombocytopenia, the purpura and leukaemia.

Description

A kind of healing thrombocytopenia, purpura, leukemia, various hemopathic medicines
[technical field]
The present invention relates to a kind of pharmaceutical formulation, relate in particular to a kind of a kind of healing thrombocytopenia that can treat multiple disease simultaneously, purpura, leukemia, various hemopathic medicines.
[background technology]
In process is cured the disease in present clinical application, generally all be to be main with the single relatively medicine of function, can not satisfy the requirement of the multiple disease of treatment.And because existing medicine a multitude of names, general patient is difficult to select the medicine treatment according to self disease oneself.
In addition, it is Western medicine greatly that existing medicine has, and not only expensive makes general ordinary people be difficult to bear, and has toxic and side effects usually, and patient is long-term or take in a large number and can cause the human body viscera damage and develop immunity to drugs, thoroughly radical curing of disease.Some people also can produce the phenomenon of vomiting when taking Western medicine, thereby has increased patient's misery.
In this case, people turn to the traditional Chinese medical science to the hope of treatment.Yet, the medicine that still unmatchful multiple disease can be treated simultaneously in the traditional Chinese medical science at present.
Therefore, for avoiding the problems referred to above, necessary a kind of healing thrombocytopenia is provided, purpura, leukemia, various hemopathic medicines are to overcome said defective of the prior art.
[summary of the invention]
For addressing the above problem, the object of the present invention is to provide a kind of therapeutic effect good, side effect is little, short treating period, and can treat a kind of healing thrombocytopenia of multiple disease simultaneously, purpura, leukemia, various hemopathic medicines.
For realizing above-mentioned purpose, the technical scheme that the present invention takes is: a kind of healing thrombocytopenia, and purpura, leukemia, various hemopathic medicines, it comprises Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Radix Et Rhizoma Rhei, Cordyceps, Herba Houttuyniae and Radix Glycyrrhizae.
A kind of healing thrombocytopenia of the present invention, purpura, leukemia, various hemopathic medicines further are: said Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Radix Et Rhizoma Rhei, Cordyceps, the proportioning of Herba Houttuyniae and Radix Glycyrrhizae is (parts by weight are represented): 10~14 parts of Ganodermas; 7~9 parts of Radix Ginsengs; 15~20 parts of Herba Epimedii; 9~11 parts of the Radixs Astragali; 10~12 parts of Radix Et Rhizoma Rhei; 6~8 parts of Cordycepses; 11~15 parts of Herba Houttuyniae; 11~15 parts in Radix Glycyrrhizae.
A kind of healing thrombocytopenia of the present invention, purpura, leukemia, various hemopathic medicines further are: said Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Radix Et Rhizoma Rhei, Cordyceps, the proportioning of Herba Houttuyniae and Radix Glycyrrhizae is (parts by weight are represented): 11 parts of Ganodermas; 8 parts of Radix Ginsengs; 17 parts of Herba Epimedii; 10 parts of the Radixs Astragali; 11 parts of Radix Et Rhizoma Rhei; 7 parts of Cordycepses; 12 parts of Herba Houttuyniae; 12 parts in Radix Glycyrrhizae.
A kind of healing thrombocytopenia of the present invention, purpura, leukemia, various hemopathic medicines can also for: said pharmaceutical formulation can be processed tablet, capsule, electuary, oral liquid or injection.
Compared with prior art, the present invention has following beneficial effect: a kind of healing thrombocytopenia of the present invention, purpura; Leukemia, various hemopathic medicines are that pure Chinese medicine is processed, and have the effect of recovering hemopoietic function; Therapeutic effect is good, and side effect is little, plurality of advantages such as short treating period; Simultaneously, this pharmaceutical formulation can be treated multiple BLOOD DISEASE simultaneously.The treatment thrombocytopenia, purpura, various hematopathys such as leukemia have instant effect to cure the characteristics that do not recur.
[specific embodiment]
Below in conjunction with embodiment the present invention is done further explanation.
Embodiment 1:
A kind of healing thrombocytopenia of treatment of the present invention, purpura, leukemia, various hemopathic medicines are made up of following Chinese medicine: Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Radix Et Rhizoma Rhei, Cordyceps, Herba Houttuyniae and Radix Glycyrrhizae.Wherein, said Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Radix Et Rhizoma Rhei, Cordyceps, the proportioning of Herba Houttuyniae and Radix Glycyrrhizae is (parts by weight are represented): 10~14 parts of Ganodermas; 7~9 parts of Radix Ginsengs; 15~20 parts of Herba Epimedii; 9~11 parts of the Radixs Astragali; 10~12 parts of Radix Et Rhizoma Rhei; 6~8 parts of Cordycepses; 11~15 parts of Herba Houttuyniae; 11~15 parts in Radix Glycyrrhizae.Said pharmaceutical formulation is processed tablet, capsule, and electuary, oral liquid or injection are to satisfy the many-sided demand of patient.
Embodiment 2:
A kind of healing thrombocytopenia of the present invention, purpura, leukemia, various hemopathic medicines are made up of following Chinese medicine: Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Radix Et Rhizoma Rhei, Cordyceps, Herba Houttuyniae and Radix Glycyrrhizae.Wherein, said Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Radix Et Rhizoma Rhei, Cordyceps, the proportioning of Herba Houttuyniae and Radix Glycyrrhizae is (parts by weight are represented): 11 parts of Ganodermas; 8 parts of Radix Ginsengs; 17 parts of Herba Epimedii; 10 parts of the Radixs Astragali; 11 parts of Radix Et Rhizoma Rhei; 7 parts of Cordycepses; 12 parts of Herba Houttuyniae; 12 parts in Radix Glycyrrhizae.Said pharmaceutical formulation is processed tablet, capsule, and electuary, oral liquid or injection are to satisfy the many-sided demand of patient.
A kind of healing thrombocytopenia of the present invention, purpura, leukemia, various hemopathic medicines are that pure Chinese medicine is processed, and have the effect of recovering hemopoietic function, and therapeutic effect is good, and side effect is little, plurality of advantages such as short treating period; Simultaneously, this pharmaceutical formulation can be treated multiple BLOOD DISEASE simultaneously.The treatment thrombocytopenia, purpura, various hematopathys such as leukemia have instant effect to cure the characteristics that do not recur.
The above specific embodiment is merely the preferred embodiment of this creation, not in order to limiting this creation, any modification of being made within all spirit and principles in this creation, is equal to replacement, improvement etc., all should be included within the protection domain of this creation.

Claims (4)

1. cure thrombocytopenia for one kind, purpura, leukemia, various hemopathic medicines is characterized in that: comprise Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Radix Et Rhizoma Rhei, Cordyceps, Herba Houttuyniae and Radix Glycyrrhizae.
2. a kind of healing thrombocytopenia as claimed in claim 1, purpura, leukemia, various hemopathic medicines is characterized in that: said Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali, Radix Et Rhizoma Rhei, Cordyceps, the proportioning of Herba Houttuyniae and Radix Glycyrrhizae is (parts by weight are represented):
10~14 parts of Ganodermas;
7~9 parts of Radix Ginsengs;
15~20 parts of Herba Epimedii;
9~11 parts of the Radixs Astragali;
10~12 parts of Radix Et Rhizoma Rhei;
6~8 parts of Cordycepses;
11~15 parts of Herba Houttuyniae;
11~15 parts in Radix Glycyrrhizae.
3. a kind of healing thrombocytopenia as claimed in claim 2, purpura, leukemia, various hemopathic medicines; It is characterized in that: said Ganoderma, Radix Ginseng, Herba Epimedii, the Radix Astragali; Radix Et Rhizoma Rhei, Cordyceps, the proportioning of Herba Houttuyniae and Radix Glycyrrhizae is (parts by weight are represented): 11 parts of Ganodermas; 8 parts of Radix Ginsengs; 17 parts of Herba Epimedii; 10 parts of the Radixs Astragali; 11 parts of Radix Et Rhizoma Rhei; 7 parts of Cordycepses; 12 parts of Herba Houttuyniae; 12 parts in Radix Glycyrrhizae.
4. a kind of healing thrombocytopenia as claimed in claim 3, purpura, leukemia, various hemopathic medicines is characterized in that: said pharmaceutical formulation can be processed tablet, capsule, electuary, oral liquid or injection.The treatment thrombocytopenia, purpura, leukemia, various hematopathys.
CN201210115326XA 2012-04-19 2012-04-19 Medicament for treating various blood diseases such as thrombocytopenia, purpura and leukaemia Pending CN102670817A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210115326XA CN102670817A (en) 2012-04-19 2012-04-19 Medicament for treating various blood diseases such as thrombocytopenia, purpura and leukaemia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210115326XA CN102670817A (en) 2012-04-19 2012-04-19 Medicament for treating various blood diseases such as thrombocytopenia, purpura and leukaemia

Publications (1)

Publication Number Publication Date
CN102670817A true CN102670817A (en) 2012-09-19

Family

ID=46803802

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210115326XA Pending CN102670817A (en) 2012-04-19 2012-04-19 Medicament for treating various blood diseases such as thrombocytopenia, purpura and leukaemia

Country Status (1)

Country Link
CN (1) CN102670817A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105641190A (en) * 2016-01-23 2016-06-08 李汶峰 Traditional Chinese medicine for treating anaphylactoid purpura
CN105833014A (en) * 2016-05-23 2016-08-10 上海市青浦区中医医院 Traditional Chinese medicine composition for treating thrombocytopenic purpura and application thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105641190A (en) * 2016-01-23 2016-06-08 李汶峰 Traditional Chinese medicine for treating anaphylactoid purpura
CN105833014A (en) * 2016-05-23 2016-08-10 上海市青浦区中医医院 Traditional Chinese medicine composition for treating thrombocytopenic purpura and application thereof

Similar Documents

Publication Publication Date Title
CN102247541A (en) Medicament for treating hepatorenal disease, diabete, asthma, rheumatism, and dermatoma
CN102697942A (en) Medicament capable of killing cancer cells and curing various tumors and cancers and leukemia
CN102697985A (en) Medicine capable of eliminating freckles and acnes, scars and moles, and various stains and wrinkles
CN102697868A (en) Medicine capable of regulating immunity and curing lupus erythematosus, urticaria and psoriasis
CN102697898A (en) Medicament for regulating endocrine and curing dysmenorrheal, mammary gland hyperplasia and breast dysplasia
CN103784602A (en) Traditional Chinese medicine for treating iron-deficiency anemia
CN102670817A (en) Medicament for treating various blood diseases such as thrombocytopenia, purpura and leukaemia
CN106902316A (en) A kind of medicine used during drug addiction treatment
CN102343038A (en) Medicament for treating cerebrosis such as hemiplegic cerebral palsy, falling sickness, Parkinson, headache, insomnia and the like
CN104922264A (en) Traditional Chinese medicine special for treating rheumatism
CN102327493A (en) Medicine for treating tracheitis, rhinitis, pharyngitis, pneumonectasis, pulmonary heart diseases and asthmatic diseases
CN102423359A (en) Drug for restoring renal functions and curing various nephrosis such as nephritis, uremia and the like
CN102327492A (en) Medicine for treating amyotrophia and myasthenia, myodystrophy and motor neuron injury
CN102343039A (en) Drug for treating skin diseases such as psoriasis, leucoderma, ichthyosis, eczema and the like
CN104688816A (en) Speckle-removing lotion
CN102343042A (en) Medicine for treating cardiovascular diseases of hypertension, cardiopathy and cerebral thrombus
CN102343040A (en) Drug for treating otitis media, deaf and tinnitus
CN104398915A (en) Traditional Chinese medicinal composition for chronic eczema
CN102343037A (en) Drug with effects of bacterium resistance, disinfection, blood circulation promotion, blood stasis removal, immunity improvement, life prolonging and aging delay
CN102327491A (en) Medicine for treating venereal diseases, such as prostatosis, condyloma acuminatum, gonorrhea syphilis and aids
CN102697869A (en) Medicine capable of regulating blood surger level, restoring pancreatic function and curing diabetes mellitus
CN102430007A (en) Weight-losing Chinese patent medicine capable of eliminating fat and treating fatty liver obesity
CN103877193A (en) Medicine for treating hepatopathy
CN102247543A (en) Hepatitis B virus killing medicine for treating hepatitis B with positive HBsAg, HBeAg and HBcAb, hepatitis B with positive HBsAg, HBeAb and HBcAb and various liver diseases
CN102343036A (en) Medicine for treating dysmenorrhoea, abnormal menstruation, impotence, premature ejaculation, and sterility infertility

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120919